| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |